This article will be expanded with more detailed information shortly.

This article will be expanded soon.

This article will be expanded soon.

This article will be expanded soon.

This article will be expanded soon.

This article will be expanded soon.

This article will be expanded soon.

This article will be expanded with more detailed information shortly.

This article will be expanded with more detailed information shortly.

This article will be expanded with more detailed information shortly.

This article will be expanded with more detailed information shortly.

This article will be expanded with more detailed information shortly.

Similar Posts

  • This article will be expanded with more detailed information shortly. This article will be expanded with more detailed information shortly. This article will be expanded with more detailed information shortly.

  • Tehran and Havana Forge Strategic Pharmaceutical Partnership with New MOU

    Iran and Cuba have signed a memorandum of understanding (MOU) to enhance international health cooperation by improving access to health products. This agreement between Iran’s FDA and Cuba’s CECMED facilitates mutual recognition of pharmaceutical companies, product registration, and a streamlined certification process. Key elements include joint educational courses and knowledge sharing for factory development. The MOU aims to advance collaborative efforts in vaccine development and laboratory diagnostics. Previous discussions between Iranian and Cuban officials have focused on strengthening medical ties, notably in vaccine production. This strategic partnership builds on over three decades of collaboration, enhancing healthcare systems in both nations.

  • This article will be expanded with more detailed information shortly. This article will be expanded soon. This article will be expanded soon. This article will be expanded soon. This article will be expanded soon. This article will be expanded soon. This article will be expanded soon. This article will be expanded with more detailed information…

  • IranPharma: A Beacon of Global Health Diplomacy and Innovation

    The 10th IranPharma Exhibition, held from September 24 to 26, has become a key event for health diplomacy in Iran’s pharmaceutical sector, attracting a record number of domestic and international participants. This year’s exhibition saw a 30% increase in visitors, highlighting growing interest in Iran’s pharmaceutical landscape. With a theme of “Sustainability, Resilience, and Innovation,” the event facilitated collaborations and agreements, particularly with Indian and Chinese companies. Iran’s pharmaceutical industry, employing over 140,000 people, is projected to increase medical exports by 16% in the upcoming year. The exhibition emphasizes Iran’s commitment to self-sufficiency and innovation in healthcare.

  • Iran Sets Ambitious Goal to Eliminate Hepatitis C by March 2027: Aiming for a Healthier Future

    The Iranian health ministry aims to eliminate hepatitis C by March 2026, backed by strategic planning and collaboration, as announced by Deputy Health Minister Alireza Raeisi. During the World Hepatitis Day 2025 webinar, he outlined a plan to identify 60% of cases and treat 40% by the target date, aspiring for bronze, silver, and gold medals in hepatitis eradication. Key initiatives include active case finding in high-risk groups, free treatment, and public awareness campaigns. Raeisi urged global support from organizations like the WHO and UNICEF, emphasizing the urgency of addressing hepatitis B and C challenges in Iran’s health system.